PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Auteur principal: | Lubaba, Anikah |
---|---|
Autres auteurs: | Fariha, Luluel Maknun |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2024
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/23252 |
Documents similaires
-
Effect of vitamin D, calcium and multiple micronutrients supplementation on lipid profile in pre-menopausal Bangladeshi garment factory workers with hypovitaminosis D
par: Islam, Md Zahirul, et autres
Publié: (2017) -
Post Covid-19 health indications of Covid-19 patients
par: Khan, Tanzim
Publié: (2022) -
Heart disease prediction using machine learning algorithms
par: Ali, Musfiq, et autres
Publié: (2019) -
হার্ট, ব্লাড, ফুড /
par: কাসেম, এম এ -
Anti-inflammatory effect of Statins in reducing the exacerbation and mortality rates of COPD patients: a review study
par: Shomi, Iffat Ara
Publié: (2019)